窑Original Article窑 Nasopharyngeal carcinoma (NPC) has an incidence of 11.76 to 20.88 per 100 000 people in Guangdong [1] . Although radiotherapybased comprehensive treatment has increased the 5year survival rate to 80% 90% in patients with early NPC [2] , conventional radical radiotherapy for NPC usually covers the posterior 1/3 to 1/2 part of the nasal cavity, middle and posterior ethmoid sinuses, and whole sphenoid sinus, resulting in nasal tissue damage commonly and causing various nasal complications, such as nasal congestion, purulent nasal discharge, and epistaxis [3, 4] . The degree of radiotherapycaused nasal mucosa damage is closely related to clinical stage, basic disease, and individual factors. Among these factors, radiation dose is the most crucial one. The relationship between radiation dose and the organ damage in radiation field and subsequent clinical symptoms are of concern. Although it is agreed that larger radiation dose will cause more serious damage, the relationship between damage and dose has not been elucidated. The main reason is that the 60 Co and linear accelerator were commonly used in radiotherapy in the past, and the doses to the posterior nasal cavity had little variety, often about 70 Gy, hence, there was no clinical basis for studying the doseeffect relationship between radiation damage and radiation. However, over the past 20 years, with the development of threedimensional conformal radiotherapy and other new radiotherapy techniques [5] , the radiation doses to the nasal cavity and normal tissue or organs surrounding the lesions are expected to decrease [6] , which provides a suitable platform for the study of doseeffect relationship of radiation and damage. Related www.cjcsysu.cn research reports promote understanding of the prevention and treatment of postradiation complications to a new degree [7] . Theoretically, it is believed that the influences of different rays on the nasal mucociliary system are certainly not the same, and greater dose leads to greater damage. But it is not clear whether this dosedamage relationship is a simply rising slant or other underlying law. The doseeffect relationship that a higher dose leads to a greater damage is only obtained from the past simple animal model. Human nasal mucociliary system has its specificity, and its irradiation reaction, tolerance, recovery degree, and other rules response to different radiation doses are different from other animals too. In fact, our clinical observations show that after intensitymodulated radiation therapy (IMRT), some patients have obvious nasal complications, whereas some patients have only mild or no nasal complications. IMRTcaused posttreatment variety makes it necessary and possible to study the relationship of different doses and damage to the nasal mucosa. As we know, the nasal cavity mainly has selfclearance, temperature and humidity control, sense of smell, resonance, and other functions, among which selfclearance function has a significant role in normal cleaning and defensiveness of the nasal cavity. Impairment of selfclearance often causes failed clearance of viruses, bacteria, fungi, and other harmful substances in the nasal cavity, resulting in sinusitis, nasal stones, and other illnesses. Mucociliary transport function directly affects the selfclearance function of the nasal cavity.
We designed a prospective cohort study using modified saccharin test with high credibility to detect the nasal mucociliary transport function in patients with NPC treated by IMRT, and analyzed the change characteristics of nasal mucociliary transport function before and after IMRT and its relationship with radiation dose to preliminarily investigate the tolerance dose of nasal mucociliary system.
The patients with NPC treated by IMRT between October 2006 and May 2009 in Sun Yatsen University Cancer Center were enrolled. The enrollment criteria included: patients with NPC treated by IMRT; 25 to 45 years old; no tumor invasion in the nasal cavity; no history of chronic rhinitis, sinusitis, severe nasal septal deviation, allergic rhinitis, and other nasal diseases; no upper respiratory tract and systemic acute inflammation 1 week before the test; no medication in the nasal cavity 1 week before the test; no previous head and neck radiotherapy for other diseases; no longterm exposure history of dust and other irritants in work environment. All patients signed informed consent.
A total of 66 patients, 46 men and 20 women, were enrolled. Their age ranged from 25 to 44 years, with a median of 37.5 years. Of the 66 patients, 61 had poorly differentiated squamous cell carcinoma, 2 had moderately differentiated squamous cell carcinoma, 1 had undifferentiated squamous cell carcinoma, and 2 had vesicular nucleus cell carcinoma. According to the 1992 Fuzhou staging system, 9 had stage I disease, 14 stage II, 32 stage III, and 11 stage IV. Fortythree patients were treated with cisplatin (DDP) plus 5fluorouracil (5FU) or with DDP alone as induction, concurrent, or adjuvant chemotherapy. One patient had a history of trauma in the right nasal cavity and physical examination showed an obvious scar on the right inferior turbinate. Therefore, this right nasal cavity was excluded from the study. Two patients had severe deviated septum reaching the inferior turbinate, and had these nasal cavities excluded. A total of 129 nasal cavities were included in our analyses.
The radiotherapy plans were designed according to the tolerance doses of tissues and organs [8] . In all patients, the mean radiation doses to sensitive organs near the lesions were less than the tolerance doses of corresponding organs. Among 132 sides of parotid glands, only 28 (21.2% ) received doses exceeding the tolerance dose. For other organs, a few (14) cases received doses exceeding the tolerance dose, accounting for less than 5% of the total (Table 1) .
On the IMRT work platform, the radiotherapy plans were retrieved, and the nasal cavity was delineated at every level, using the junction of bone and mucosa as the boundary of delineation area. The radiation doses to the 129 nasal cavities ranged from 23.14 to 56.38 Gy, with a mean of (36.46 依 11.23) Gy, given by 30 fractions. The mean radiation dose to the nasal cavity was automatic calculated by computer.
Before and at the end of radiotherapy, all included nasal cavities were examined by modified saccharin test. Patients were in sitting up position with quiet nasal breathing. Saccharin crystal particles with diameters of about 2.5 mm 伊 0.5 mm were selected (Guangzhou Tianguan Food Additive Co., Ltd, lot number: 20060802) . A grain of saccharin stained by methylene blue was placed on the surface of inside mucosa 1.0 cm behind the inferior turbinate by a gunshaped forceps, then timing started at this time. Patients were asked to swallow every 20 s. The oropharynx was observed every 2 min. The time was recorded when the blue matter moved to posterior pharyngeal surface equivalent to the lower edge of soft palate. The time gap between two records was the total time saccharin migrating on the mucosal surface. If the blue still could not be seen on the posterior pharyngeal wall in 2hour observation, the test was stopped, and the mucociliary transport rate (MRT) was recorded as 0. During the test, patients could not cough, blow nose, lean forward or backward. A fine cotton swab with marked scale was inserted from the front nostril to the posterior pharyngeal wall to measure the distance between saccharin placement to the posterior pharyngeal wall. MTR was calculated according to a formula: MTR = distance (mm) / time (min).
All patients underwent at least one modified saccharin test after radiotherapy, with 115 nasal cavities examined at 3 months after radiotherapy, 108 at 6 months and 111 at 12 months, respectively. Among 129 nasal cavities, 114 were examined at least 2 times after radiotherapy.
All tests or examinations were performed by the same investigator and checked by two superior doctors. The data were inputted into the computer by two people to set up Excel forms for data checking.
The SPSS13.0 statistical software was applied to establish a database for statistical analysis . < 0 . 05 was considered as statistical significance. Quantitative data are presented as mean ± standard deviation (字 依 s), and qualitative data are presented as percentage or rate (%).
The study found that when the dose was larger than a certain dose, the MTR ratio (the ratio of postIMRT MTR to preIMRT MTR) changed significantly, then maintained at a low level. The dose at this level was considered as the threshold dose. To determine the threshold dose of saccharin tests at different phrases more objectively, a segmented regression model [9] (Formula 1) taking radiation dose as the independent variable was used to describe the mean MTR ratio. Setting m as the threshold dose, independent variables were divided into low dose (臆 m) group and highdose (> m) group. Data in low dose group were put into the equation 1 and data in high dose group were put into the equation 2 to determine the equation coefficient.
By analyzing the scatter diagram, the possible value of m was estimated and the independent variables determined by m values were iteratively put into the equation. When the equation had the maximal determination coefficient R2, m was determined as the threshold dose value.
Other statistical methods included test, ANOVA, and multiple linear regression analysis.
The MTR ratio (%MTR) could reflect the impact of rays on MTR, therefore, %MTR was selected as a main observation indicator. The relationship between % MTR and radiation doses at different time are demonstrated in a scatter diagram (Figure 1) .
At the end of radiotherapy, and at 3 and 12 months after radiotherapy, the threshold dose was 37 Gy. At 6 months after radiotherapy, the threshold dose was 39 Gy. To facilitate descriptions, the data of % MTR were divided into high and low dose groups according to threshold dose.
In the low dose group, at the end of radiotherapy, and at 3, 6, 12 months after radiotherapy, the %MTR were (62.82 依 
www.cjcsysu.cn 38.59)%, (56.78 依 37.79)% , (64.05 依 39.37)%, and (71.13 依 39.55)% , respectively, with significant differences among them ( < 0.05). The damage of the nasal mucosa did not stop after the end of radiotherapy. During the 1year observation, the %MTR was the minimum at 3 months after radiotherapy, then increased over time.
In high dose group, the % MTR kept at a low level: at the end of radiotherapy, at 3, 6, 12 months after radiotherapy, the % MTR were (15.41 依 7.21)% , (15.76 ± 7.28)% , (16.57 依 7.62)% , and (14.84 ± 7.55)% respectively, with no significant difference among them ( > 0.05) .
Before radiotherapy, the mean MTR was (8.24 依 3.27) mm/min. At the end of radiotherapy, the mean MTR significantly decreased to only 40.59% of preIMRT value. During 1year observation, the MTR was the minimum at 3 months after radiotherapy (only 38.27% of preIMRT value), and gradually increased after then, indicating gradual recovery of the nasal mucociliary function. The MTR increased to 48.90% of preIMRT value at 12 months after radiotherapy.
The radiation dose to the nasal cavity, gender, age, stage , chemotherapy , and the time after radiotherapy were considered as independent variables, and %MTR was considered as a dependent variable to establish a multiple linear regression model. The result showed that only the radiation dose to the nasal cavity was the independent factor affecting %MTR ( < 0.05) ( Table 2 ).
Due to the limitation of current radiotherapy techniques, to ensure adequate radiation dose to lesions, it is inevitable for some sensitive organs close to lesions receiving dose greater than the tolerance dose. Kwong .
[10] analyzed the data of 33 patients with early stage NPC treated with IMRT in Hong Kong Queen Mary Hospital. They found that the mean dose to the parotid glands was 38.8 Gy, higher than the tolerance dose. Among our patients, 28 had the parotid gland receiving a mean dose [(31.56 依 8.67 ) Gy] higher than the tolerance dose, only a few had other organs receiving a mean dose higher more than the tolerance dose ( Table 1 ). The NPC target delineation for our patients was based on the principle in the reference [11] . The radiotherapy plan was reasonable.
In this study, we observed the changes of nasal MTR before and after radiotherapy to preliminarily explore the relationship between radiation dose and the nasal mucociliary system damage and the tolerance dose of the nasal mucociliary system. Previous studies showed that the determination of the tolerance dose of sensitive tissues or organs near the lesions and the outcomes after radiotherapy is important in making comprehensive radiotherapy plan to control the radiation doses to sensitive tissues or organs in reasonable ranges. According to the tolerance dose of parotid gland reported by Eisbruch . [12] , we propose to Figure 1 The mucus transfer rate ratio (%MTR) at the end of the radiotherapy, and 3, 6, 12 months after radiotherapy
The %MTR value is the ratio of the post鄄 radiotherapy MTR to the pre鄄 radiotherapy MTR. limit the volume dose to twothirds of the parotid within 32 Gy in all patients with head and neck cancer treated with radiotherapy [8] . However, at present, the radiationdamage of the nasal mucociliary system has not been studied by using a similar thinking.
The threshold doses to the nasal mucus at different stages were calculated with a segmented regression model. At the end of radiotherapy, and at 3, 6, 12 months after radiotherapy, the threshold doses to the nasal mucus were 37, 37, 39, and 37 Gy. The above findings and the changes of the indicators after radiotherapy indicated that a dose less than 37 Gy to the nasal cavity caused less damage to the transfer function of the nasal mucociliary system. During the observation period, the nasal MTR recovered gradually. Therefore, we propose that the tolerance dose of the nasal mucus is 37 Gy.
Our results suggested that nasal mucosa damage did not stop since the end of radiotherapy, and the damage of nasal mucociliary transfer function at 3 months after radiotherapy was more severe than that at the end of radiotherapy. Through histological study, Wang . [13] showed that the middle ear mucosa damage caused by radiation continued to aggravate after the cessation of radiotherapy, and the collapse and deficiency of the mucosa epithelial cilia at 3 months after radiotherapy was more obvious than that at 1 month before radiotherapy. This continuous damage may be mainly related to the delayed effect of radiation, which means radiation damage effect continues after radiotherapy [14] . In a clinical study on 32 patients treated with conventional radiotherapy, Kamel .
[15] also observed a continuous decrease of the nasal MTR, which became stable and persistent at 6 months after radiotherapy.
Nasal complications can be reduced by applying clinical interventions for the nasal cavity during and after radiotherapy. We observed that the nasal mucosa damage aggravated continuously from the beginning of radiotherapy to 3 months after radiotherapy, which was the developing period of nasal cavity complications. From 3 months to 1 year after radiotherapy, the function of the nasal mucociliary system recovered gradually, but did not yet return to normal. During this period, nasal mucosa congestion, nasal discharge, crusting, nasal bleeding could still be observed by using front nose scope or nasal endoscope. Therefore, we suggest that in 1 year after radiotherapy some methods such as nasal irrigation can be used to reduce the edema, secretions, and other situations caused by nasal mucosa dysfunction, and the period from the beginning to time 3 months after radiotherapy is a critical period to prevent nasal complications. Timely and effective clinical intervention is important in preventing nasal cavity complications and improving the quality of life of patients.
In this study, the multiple regression analysis of the relationship between the nasal MTR and the radiation dose to the nasal cavity, gender, age, stage, chemotherapy, and the time after radiotherapy showed that only the radiation dose to the nasal cavity was the independent factor affecting the nasal MTR. Therefore, the determination of the tolerance dose to the nasal mucociliary system is important in protecting the nasal mucociliary system during radiotherapy. With the development of radiation techniques, the indepth understanding of radiationcaused complications, and patients爷 improved requirements for quality of life, investigators will pay more attention to control the local radiation dose to the nasal cavity technically and improve the understanding of the nasal mucociliary system protection. Our preliminary research shows that, while ensuring the radiation dose to NPC lesions, controlling the radiation dose to the nasal cavity within 37 Gy via advanced radiotherapy technique can protect the transfer function of the nasal mucociliary system reasonably. How to improve the data such as changes of the nasal cavity morphology and quality of life related to nasal cavity, and explore the tolerance dose to the nasal mucosa should be further studied.
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